Pembrolizumab efficacy in a tumor mutation burden-high glioblastoma patient: A case study and implications for precision oncology.
Nishiyama A, Sato S, Sakaguchi H, Kotani H, Yamashita K, Ohtsubo K, Sekiya T, Watanabe A, Tajima A, Shimaguchi C, Mizuguchi K, Ikeda H, Kinoshita M, Nakada M, Takeuchi S.
Nishiyama A, et al. Among authors: sekiya t.
Cancer Sci. 2025 Jan;116(1):271-276. doi: 10.1111/cas.16370. Epub 2024 Oct 25.
Cancer Sci. 2025.
PMID: 39453824
Free PMC article.